The latest lymphoma news
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy…
By Sue Dunlevy – Herald Sun. IN a breakthrough that could extend hundreds of lives,…
A new study links a father’s age at birth to the risk that his child…
By Delaine Smith, ALLG CEO. The ALLG Discovery Centre is an innovative state-of-the-art facility that holds…
Correctly diagnosing a person with cancer—and identifying the specific type of cancer—makes all the difference…
A UK National Cancer Research Institute trial led from The University of Manchester and the Christie NHS Foundation Trust has suggested…
ASH: New data demonstrates Hodgkin lymphoma (HL) patients at risk of relapse following an autologous stem…
An new treatment for relapsed or refractory systemic anaplastic large cell lymphoma (sALCL) has been listed…
Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and Harvard-affiliated hospitals…
At least 2 percent of people over age 40 and 5 percent of people over…